Hyundai Pharmaceutical Co Ltd
KRX:004310
Hyundai Pharmaceutical Co Ltd
KRX:004310
Price:
11 700
KRW
0.78%
Market Closed
Market Cap:
₩305.8B
Add
Note
Why Create Notes?
Capture your thoughts
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Hyundai Pharmaceutical Co Ltd
11700
+90 (+0.78%)
| 52 Week Range |
3 000
13 550
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Delete Alert
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Hyundai Pharmaceutical Co Ltd
Hyundai Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Hyundai Pharmaceutical Co Ltd
Hyundai Pharmaceutical Co Ltd
Balance Sheet
Hyundai Pharmaceutical Co Ltd
Hyundai Pharmaceutical Co Ltd
Currency: KRW
| Nov-2001 | Nov-2002 | Nov-2003 | Nov-2004 | Nov-2005 | Nov-2006 | Nov-2007 | Nov-2008 | Nov-2009 | Nov-2010 | Nov-2011 | Nov-2012 | Nov-2013 | Nov-2014 | Nov-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | Nov-2022 | Nov-2023 | Nov-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
14 943
|
6 560
|
18 499
|
18 693
|
17 346
|
18 112
|
15 853
|
12 875
|
7 531
|
11 320
|
13 629
|
16 267
|
14 087
|
13 790
|
10 409
|
8 622
|
8 234
|
7 362
|
7 405
|
13 272
|
21 628
|
30 266
|
16 203
|
10 277
|
|
| Cash Equivalents |
14 943
|
6 560
|
18 499
|
18 693
|
17 346
|
18 112
|
15 853
|
12 875
|
7 531
|
11 320
|
13 629
|
16 267
|
14 087
|
13 790
|
10 409
|
8 622
|
8 234
|
7 362
|
7 405
|
13 272
|
21 628
|
30 266
|
16 203
|
10 277
|
|
| Short-Term Investments |
2 741
|
9 314
|
523
|
1 118
|
3 437
|
4 637
|
10 189
|
310
|
120
|
0
|
343
|
343
|
543
|
0
|
0
|
0
|
0
|
0
|
93
|
6 612
|
288
|
3 513
|
2 088
|
0
|
|
| Total Receivables |
27 476
|
32 779
|
32 378
|
33 709
|
36 185
|
37 630
|
38 481
|
46 396
|
55 078
|
52 405
|
55 969
|
45 322
|
44 763
|
46 003
|
47 280
|
54 267
|
59 598
|
43 829
|
45 100
|
42 358
|
40 336
|
42 461
|
38 973
|
38 652
|
|
| Accounts Receivables |
27 451
|
32 750
|
32 306
|
33 641
|
35 694
|
36 954
|
37 642
|
44 781
|
53 203
|
50 942
|
54 071
|
43 144
|
42 607
|
43 783
|
47 280
|
51 032
|
56 575
|
41 008
|
41 564
|
39 426
|
36 871
|
37 374
|
38 378
|
37 666
|
|
| Other Receivables |
25
|
29
|
72
|
68
|
491
|
676
|
839
|
1 615
|
1 875
|
1 463
|
1 898
|
2 178
|
2 156
|
2 220
|
0
|
3 235
|
3 023
|
2 821
|
3 536
|
2 932
|
3 465
|
5 087
|
595
|
986
|
|
| Inventory |
13 490
|
12 630
|
10 938
|
12 084
|
13 623
|
17 099
|
17 088
|
14 128
|
16 015
|
14 026
|
17 058
|
24 100
|
20 971
|
19 359
|
18 556
|
17 118
|
17 206
|
17 453
|
17 925
|
17 338
|
22 022
|
24 076
|
26 998
|
29 085
|
|
| Other Current Assets |
438
|
477
|
360
|
81
|
96
|
582
|
333
|
2 582
|
339
|
564
|
510
|
142
|
113
|
118
|
124
|
96
|
1 892
|
748
|
1 122
|
922
|
622
|
1 327
|
1 211
|
1 548
|
|
| Total Current Assets |
59 089
|
61 759
|
62 698
|
65 685
|
70 686
|
78 059
|
81 945
|
76 291
|
79 082
|
78 314
|
87 510
|
86 174
|
80 477
|
79 269
|
76 369
|
80 103
|
86 930
|
69 392
|
71 644
|
80 503
|
84 896
|
101 643
|
85 473
|
79 562
|
|
| PP&E Net |
26 569
|
27 879
|
27 568
|
26 772
|
26 479
|
28 380
|
35 429
|
47 737
|
46 320
|
43 167
|
40 726
|
33 097
|
33 346
|
32 705
|
32 454
|
32 655
|
33 000
|
32 015
|
30 592
|
29 567
|
29 261
|
28 601
|
29 436
|
37 446
|
|
| PP&E Gross |
26 569
|
27 879
|
27 568
|
26 772
|
26 479
|
28 380
|
35 429
|
47 737
|
46 320
|
43 167
|
40 726
|
0
|
0
|
32 705
|
32 454
|
32 655
|
33 000
|
32 015
|
0
|
29 567
|
29 261
|
28 601
|
29 436
|
37 446
|
|
| Accumulated Depreciation |
6 786
|
8 236
|
10 098
|
11 879
|
13 622
|
15 205
|
16 751
|
17 549
|
19 278
|
20 450
|
19 724
|
0
|
0
|
24 246
|
25 925
|
27 583
|
29 699
|
31 926
|
0
|
36 925
|
38 737
|
40 698
|
40 494
|
43 051
|
|
| Intangible Assets |
99
|
85
|
303
|
292
|
591
|
619
|
619
|
687
|
502
|
379
|
2 448
|
2 411
|
1 829
|
1 794
|
1 749
|
3 204
|
3 796
|
7 534
|
7 695
|
12 541
|
13 467
|
17 301
|
5 632
|
6 718
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
48
|
48
|
0
|
0
|
0
|
|
| Long-Term Investments |
5 143
|
5 190
|
4 580
|
4 710
|
4 370
|
6 174
|
5 126
|
4 936
|
7 010
|
7 375
|
24 325
|
25 832
|
26 020
|
31 978
|
34 421
|
30 574
|
29 474
|
30 743
|
30 457
|
28 814
|
29 312
|
29 793
|
30 555
|
27 721
|
|
| Other Long-Term Assets |
1 088
|
801
|
1 425
|
1 378
|
896
|
1 128
|
1 081
|
1 050
|
1 353
|
1 747
|
1 939
|
2 388
|
1 731
|
1 548
|
1 545
|
1 692
|
1 417
|
6 423
|
6 851
|
6 029
|
6 874
|
3 821
|
3 533
|
4 949
|
|
| Total Assets |
91 988
N/A
|
95 714
+4%
|
96 574
+1%
|
98 839
+2%
|
103 022
+4%
|
114 361
+11%
|
124 200
+9%
|
130 702
+5%
|
134 268
+3%
|
130 982
-2%
|
156 948
+20%
|
149 903
-4%
|
143 403
-4%
|
147 294
+3%
|
146 538
-1%
|
148 228
+1%
|
154 617
+4%
|
146 106
-6%
|
147 240
+1%
|
157 502
+7%
|
163 857
+4%
|
181 159
+11%
|
154 629
-15%
|
156 396
+1%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
5 782
|
4 965
|
4 944
|
4 669
|
3 603
|
2 908
|
3 215
|
4 164
|
5 133
|
3 162
|
5 077
|
5 561
|
6 855
|
8 488
|
7 274
|
9 907
|
11 021
|
12 952
|
11 536
|
12 693
|
16 553
|
18 072
|
11 833
|
10 112
|
|
| Accrued Liabilities |
2 746
|
1 855
|
1 312
|
1 601
|
1 016
|
1 248
|
1 411
|
1 558
|
1 709
|
1 247
|
562
|
554
|
402
|
496
|
563
|
877
|
941
|
1 374
|
0
|
1 854
|
2 626
|
3 110
|
2 679
|
2 739
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26 936
|
29 453
|
21 000
|
21 000
|
24 000
|
14 000
|
29 000
|
38 000
|
32 950
|
|
| Current Portion of Long-Term Debt |
183
|
270
|
727
|
0
|
49
|
0
|
0
|
19 002
|
23 522
|
22 000
|
27 819
|
29 286
|
20 750
|
18 764
|
21 000
|
0
|
0
|
0
|
0
|
416
|
521
|
352
|
624
|
331
|
|
| Other Current Liabilities |
14 025
|
11 187
|
9 002
|
8 498
|
9 561
|
9 689
|
11 574
|
8 594
|
7 821
|
9 064
|
11 599
|
8 418
|
8 637
|
8 190
|
8 651
|
6 804
|
7 602
|
14 179
|
16 882
|
12 816
|
12 151
|
30 162
|
12 198
|
12 555
|
|
| Total Current Liabilities |
22 735
|
18 278
|
15 986
|
14 768
|
14 229
|
13 845
|
16 200
|
33 317
|
38 185
|
35 473
|
45 057
|
43 820
|
36 644
|
35 938
|
37 488
|
44 524
|
49 017
|
49 505
|
49 418
|
51 779
|
45 850
|
80 696
|
65 334
|
58 687
|
|
| Long-Term Debt |
729
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
206
|
15 324
|
10 090
|
581
|
14 798
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
82
|
1 343
|
1 843
|
1 063
|
588
|
883
|
3 597
|
2 126
|
1 932
|
2 533
|
1 490
|
295
|
452
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
460
|
462
|
507
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2 641
|
5 534
|
5 258
|
5 601
|
5 336
|
4 258
|
2 789
|
3 690
|
2 897
|
2 121
|
3 978
|
4 270
|
3 615
|
4 137
|
3 128
|
5 646
|
7 049
|
8 476
|
13 644
|
15 376
|
16 082
|
3 818
|
4 053
|
3 837
|
|
| Total Liabilities |
26 105
N/A
|
23 812
-9%
|
21 244
-11%
|
20 369
-4%
|
19 647
-4%
|
19 445
-1%
|
20 833
+7%
|
38 071
+83%
|
41 670
+9%
|
38 477
-8%
|
53 092
+38%
|
50 678
-5%
|
42 697
-16%
|
42 608
0%
|
42 105
-1%
|
50 465
+20%
|
56 518
+12%
|
57 980
+3%
|
63 062
+9%
|
67 361
+7%
|
77 257
+15%
|
94 604
+22%
|
69 968
-26%
|
77 322
+11%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
14 000
|
16 000
|
16 000
|
16 000
|
16 000
|
16 000
|
16 000
|
16 000
|
|
| Retained Earnings |
34 433
|
40 668
|
44 367
|
48 097
|
52 661
|
57 546
|
65 215
|
66 591
|
66 662
|
68 406
|
80 230
|
74 419
|
75 362
|
74 795
|
75 637
|
72 404
|
72 470
|
52 833
|
51 966
|
52 292
|
48 355
|
49 602
|
52 949
|
50 104
|
|
| Additional Paid In Capital |
2 842
|
2 819
|
3 040
|
3 303
|
3 949
|
7 010
|
6 684
|
6 684
|
6 386
|
6 386
|
6 386
|
6 386
|
6 386
|
6 386
|
7 092
|
7 610
|
7 610
|
15 718
|
35 381
|
20 471
|
20 471
|
20 654
|
20 654
|
20 654
|
|
| Unrealized Security Profit/Loss |
17 452
|
17 208
|
16 668
|
16 749
|
17 141
|
17 472
|
17 467
|
17 237
|
17 024
|
17 245
|
16 773
|
17 066
|
18 490
|
23 038
|
18 772
|
16 545
|
19 170
|
17 768
|
852
|
16 447
|
16 844
|
16 895
|
15 457
|
14 773
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13 532
|
13 532
|
11 068
|
12 796
|
15 152
|
16 606
|
0
|
15 070
|
15 070
|
16 596
|
0
|
22 457
|
|
| Other Equity |
2 843
|
2 792
|
2 746
|
3 679
|
4 376
|
1 112
|
0
|
11 880
|
11 474
|
13 532
|
13 532
|
12 646
|
0
|
0
|
0
|
0
|
0
|
2 413
|
18 317
|
0
|
0
|
0
|
20 400
|
22 457
|
|
| Total Equity |
65 883
N/A
|
71 902
+9%
|
75 330
+5%
|
78 470
+4%
|
83 375
+6%
|
94 916
+14%
|
103 367
+9%
|
92 631
-10%
|
92 598
0%
|
92 505
0%
|
103 857
+12%
|
99 225
-4%
|
100 705
+1%
|
104 687
+4%
|
104 432
0%
|
97 763
-6%
|
98 098
+0%
|
88 126
-10%
|
84 178
-4%
|
90 141
+7%
|
86 600
-4%
|
86 555
0%
|
84 661
-2%
|
79 074
-7%
|
|
| Total Liabilities & Equity |
91 988
N/A
|
95 714
+4%
|
96 574
+1%
|
98 839
+2%
|
103 022
+4%
|
114 361
+11%
|
124 200
+9%
|
130 702
+5%
|
134 268
+3%
|
130 982
-2%
|
156 948
+20%
|
149 903
-4%
|
143 403
-4%
|
147 294
+3%
|
146 538
-1%
|
148 228
+1%
|
154 617
+4%
|
146 106
-6%
|
147 240
+1%
|
157 502
+7%
|
163 857
+4%
|
181 159
+11%
|
154 629
-15%
|
156 396
+1%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
27
|
27
|
27
|
25
|
25
|
28
|
29
|
25
|
25
|
24
|
24
|
24
|
24
|
24
|
25
|
25
|
24
|
27
|
27
|
28
|
28
|
28
|
27
|
26
|
|
Switch to:
Switch to:
See Also
Discover More
